Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomics, |
RCV000768341 | SCV000899032 | uncertain significance | Epidermodysplasia verruciformis, susceptibility to, 1 | 2018-12-03 | criteria provided, single submitter | clinical testing | TMC8 NM_152468.4 exon12 p.Ile509Val (c.1525A>G): This variant has not been reported in the literature but is present in 0.01% (1/16178) of African alleles in in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/17-76134261-A-G). This variant amino acid Valine (Val) is present in several species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Center for Genomics, |
RCV003224462 | SCV003920569 | uncertain significance | Epidermodysplasia verruciformis, susceptibility to, 2 | 2021-03-30 | criteria provided, single submitter | clinical testing | TMC8 NM_152468.4 exon12 p.Ile509Val (c.1525A>G): This variant has not been reported in the literature but is present in 0.01% (1/16178) of African alleles in in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/17-76134261-A-G). This variant amino acid Valine (Val) is present in several species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |